Events2Join

Bristol Myers Squibb


Bristol-Myers Squibb - Walton Isaacson

When you open your mind, you really are opening up your possibilities – for yourself, fellow employees, the company and the patients. We created the campaign ...

OPDIVO® (nivolumab)

You or your healthcare provider should contact Bristol Myers Squibb at 1-844-593-7869 as soon as you become aware of a pregnancy. Tell your healthcare ...

Bristol Myers's stock soars after AbbVie's schizophrenia-drug trial ...

Bristol Myers Squibb Co. shares surged on Monday after rival AbbVie Inc. reported disappointing results from the trial of a new ...

Bristol-Myers Squibb Co. v. Matrix Labs. Ltd. - Casetext

The motion turns on a discrete provision in the parties' agreement. In relevant part, the agreement prohibited MLL from selling certain prescription drugs to " ...

BMS Impact on FLSA Cases Jurisdictional Split Explained

Explore how federal courts diverge on applying Bristol-Myers Squibb's jurisdiction ruling to FLSA cases involving non-resident plaintiffs ...

Bristol-Myers Squibb Children's Hospital - RWJBarnabas Health

A dedicated pediatric teaching facility, BMSCH offers the highest levels of pediatric care available in a family-centered healing environment.

Partner Spotlight: Bristol Myers Squibb

At Bristol Myers Squibb, our teams in Washington discover, develop, and deliver innovative cell-based therapies and biotherapeutics to treat serious diseases.

Bristol Myers Squibb | MVA - Medicon Valley Alliance

Our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb focuses its research ...

bristol-myers squibb pharmaceuticals limited - Companies House

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, ...

Bristol Myers Squibb on X: "#MEDIA: The @US_FDA granted ...

MEDIA: The @US_FDA granted approval for a new treatment for #schizophrenia in adult, representing the first new class of medicine for ...

Bristol Myers Squibb Receives Positive CHMP Opinion for ...

Bristol Myers Squibb is inspired by a single vision — transforming patients' lives through science. The goal of the company's cancer research is ...

The Impact of Bristol-Myers Squibb on FLSA Forum-Shopping

In 2017, the U.S. Supreme Court issued its ruling in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County (“BMS”), ...

Bristol-Myers Squibb - Veteran Jobs Mission

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail ...

Bristol Myers Faces Renewed, $6.7 Billion Lawsuit Over Delayed ...

NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock

Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, ...

Bristol Myers Squibb Careers and Employment

Company Overview. At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these ...

Bristol-Myers Squibb Company Stock (BMY) - Quote Nyse

Bristol-Myers Squibb Company (BMY.NYSE): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Bristol-Myers Squibb Company ...

Bristol-Myers Squibb Co - JUST Capital

Bristol-Myers Squibb is a global biopharmaceutical company manufacturing and selling prescription drugs worldwide.

BMY Bristol-Myers Squibb Company Stock Price & Overview

A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...

Bristol Myers Squibb hit with renewed $6.7bn charge over delayed ...

Bristol Myers Squibb is facing a renewed $6.7bn lawsuit over delayed drug approvals in the US, allegedly avoiding payouts to Celgene ...